<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="22/05/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10225377" creator="Yo Shidahara">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>10225377</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Activation of <term sem="Protein_complex" id="T1" lex="nuclear_factor-kappaB">nuclear factor-kappaB</term> by <term sem="Lipid" id="T2" lex="lipopolysaccharide">lipopolysaccharide</term> in <term sem="Cell_natural" id="T3" lex="mononuclear_leukocyte">mononuclear leukocytes</term> is prevented by <term sem="Other" id="A1">inhibitors of <term sem="Protein_molecule" id="T4" lex="cytosolic_phospholipase_A2">cytosolic phospholipase A2</term></term>.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="T1" />
<cause idref="T2" />
<clue><clueType>Activation</clueType> <linkTheme>of</linkTheme> nuclear factor-kappaB <linkCause>by</linkCause> lipopolysaccharide <clueLoc>in mononuclear leukocytes</clueLoc> is prevented by inhibitors of cytosolic phospholipase A2.</clue>
<comment>TPS A1</comment>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="E1" />
<cause idref="A1" />
<clue>Activation of nuclear factor-kappaB by lipopolysaccharide in mononuclear leukocytes is <clueType>prevented</clueType> <linkCause>by</linkCause> inhibitors of cytosolic phospholipase A2.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">In <term sem="Cell_natural" id="T5" lex="monocyte">monocytes</term>, <term sem="Lipid" id="T6" lex="lipopolysaccharide">lipopolysaccharide</term> induces synthesis and activity of the 85-kDa <term sem="Protein_molecule" id="T7" lex="cytosolic_phospholipase_A2">cytosolic phospholipase A2</term>.</sentence>
<event id="E3">
<type class="Gene_expression" />
<theme idref="T7" />
<clue>In monocytes, lipopolysaccharide induces <clueType>synthesis</clueType> and activity <linkTheme>of</linkTheme> the 85-kDa cytosolic phospholipase A2.</clue>
</event>
<event id="E4">
<type class="Positive_regulation" />
<theme idref="E3" />
<cause idref="T6" />
<clue><clueLoc>In monocytes</clueLoc>, lipopolysaccharide <clueType>induces</clueType> synthesis and activity of the 85-kDa cytosolic phospholipase A2.</clue>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="T7" />
<cause idref="T6" />
<clue><clueLoc>In monocytes</clueLoc>, lipopolysaccharide <clueType>induces</clueType> synthesis and activity of the 85-kDa cytosolic phospholipase A2.</clue>
</event>
<sentence id="S3">This enzyme releases <term sem="Organic_compound_other" id="T8" lex="arachidonic_acid">arachidonic acid</term> and <term sem="Lipid" id="T9" lex="lyso-phospholipid">lyso-phospholipids</term> from membranes which are metabolized to <term sem="Organic_compound_other" id="T10" lex="eicosanoid">eicosanoids</term> and <term sem="Organic_compound_other" id="T11" lex="platelet-activating-factor">platelet-activating-factor</term>.</sentence>
<event id="E6">
<type class="Localization" />
<theme idref="T8" />
<theme idref="T9" />
<clue>This enzyme <clueType>releases</clueType> arachidonic acid and lyso-phospholipids <clueLoc>from membranes</clueLoc> which are metabolized to eicosanoids and platelet-activating-factor.</clue>
</event>
<event id="E107">
<type class="Positive_regulation" />
<theme idref="E6" />
<cause idref="T7" />
<clue><corefCause>This enzyme</corefCause> <clueType>releases</clueType> arachidonic acid and lyso-phospholipids from membranes which are metabolized to eicosanoids and platelet-activating-factor.</clue>
</event>
<event id="E7">
<type class="Metabolism" />
<theme idref="T8" />
<theme idref="T10" />
<clue>This enzyme releases arachidonic acid and lyso-phospholipids from membranes <corefTheme>which</corefTheme> are <clueType>metabolized</clueType> <linkTheme>to</linkTheme> eicosanoids and platelet-activating-factor.</clue>
</event>
<event id="E8">
<type class="Metabolism" />
<theme idref="T9" />
<theme idref="T11" />
<clue>This enzyme releases arachidonic acid and lyso-phospholipids from membranes <corefTheme>which</corefTheme> are <clueType>metabolized</clueType> <linkTheme>to</linkTheme> eicosanoids and platelet-activating-factor.</clue>
</event>
<sentence id="S4">These lipid mediators increase activity of <term sem="Protein_family_or_group" id="T12" lex="transcription_factor">transcription factors</term> and expression of <term sem="DNA_family_or_group" id="T13" lex="cytokine_gene">cytokine genes</term> indicating a function for <term sem="Protein_molecule" id="T14" lex="cytosolic_phospholipase_A2">cytosolic phospholipase A2</term> in <term sem="Other" id="T15" lex="signal_transduction">signal transduction</term> and <term sem="Other" id="T16" lex="inflammation">inflammation</term>.</sentence>
<event id="E9">
<type class="Gene_expression" />
<theme idref="T13" />
<clue>These lipid mediators increase activity of transcription factors and <clueType>expression</clueType> <linkTheme>of</linkTheme> cytokine genes indicating a function for cytosolic phospholipase A2 in signal transduction and inflammation.</clue>
</event>
<event id="E10">
<type class="Positive_regulation" />
<theme idref="T12" />
<cause idref="T10" />
<clue><corefCause>These lipid mediators</corefCause> <clueType>increase</clueType> activity of transcription factors and expression of cytokine genes indicating a function for cytosolic phospholipase A2 in signal transduction and inflammation.</clue>
</event>
<event id="E11">
<type class="Positive_regulation" />
<theme idref="T12" />
<cause idref="T11" />
<clue><corefCause>These lipid mediators</corefCause> <clueType>increase</clueType> activity of transcription factors and expression of cytokine genes indicating a function for cytosolic phospholipase A2 in signal transduction and inflammation.</clue>
</event>
<event id="E12">
<type class="Positive_regulation" />
<theme idref="E9" />
<cause idref="T10" />
<clue><corefCause>These lipid mediators</corefCause> <clueType>increase</clueType> activity of transcription factors and expression of cytokine genes indicating a function for cytosolic phospholipase A2 in signal transduction and inflammation.</clue>
</event>
<event id="E13">
<type class="Positive_regulation" />
<theme idref="E9" />
<cause idref="T11" />
<clue><corefCause>These lipid mediators</corefCause> <clueType>increase</clueType> activity of transcription factors and expression of cytokine genes indicating a function for cytosolic phospholipase A2 in signal transduction and inflammation.</clue>
</event>
<event id="E14">
<type class="Regulation" />
<theme idref="T15" />
<cause idref="T14" />
<clue>These lipid mediators increase activity of transcription factors and expression of cytokine genes indicating a <clueType>function</clueType> <linkCause>for</linkCause> cytosolic phospholipase A2 <linkTheme>in</linkTheme> signal transduction and inflammation.</clue>
</event>
<event id="E15">
<type class="Regulation" />
<theme idref="T16" />
<cause idref="T14" />
<clue>These lipid mediators increase activity of transcription factors and expression of cytokine genes indicating a <clueType>function</clueType> <linkCause>for</linkCause> cytosolic phospholipase A2 <linkTheme>in</linkTheme> signal transduction and inflammation.</clue>
</event>
<sentence id="S5">We have shown previously that <term sem="Organic_compound_other" id="A3"><term sem="Organic_compound_other" id="T17" lex="trifluoromethylketone_inhibitor">trifluoromethylketone inhibitors</term> of <term sem="Protein_molecule" id="T18" lex="cytosolic_phospholipase_A2">cytosolic phospholipase A2</term></term> suppressed <term sem="Protein_molecule" id="T19" lex="interleukin-1beta_protein">interleukin-1beta</term> <term sem="Protein_molecule" id="A2">protein</term> and <term sem="RNA_molecule" id="T20" lex="steady-state_mRNA_level">steady-state mRNA</term> levels in human <term sem="Cell_natural" id="T21" lex="lipopolysaccharide-stimulated_peripheral_blood_mononuclear_leukocyte"><term sem="Lipid" id="T22" lex="lipopolysaccharide">lipopolysaccharide</term>-stimulated peripheral blood <term sem="Cell_natural" id="T23" lex="mononuclear_leukocyte">mononuclear leukocytes</term></term>.</sentence>
<event id="E16">
<type class="Negative_regulation" />
<theme idref1="A2" idref="T19" />
<cause idref="A3" />
<clue>We have shown previously that trifluoromethylketone inhibitors of cytosolic phospholipase A2 <clueType>suppressed</clueType> interleukin-1beta protein and steady-state mRNA levels <clueLoc>in human lipopolysaccharide-stimulated peripheral blood mononuclear leukocytes</clueLoc>.</clue>
<comment>NER T19 mod, TPS A3</comment>
</event>
<event id="E17">
<type class="Negative_regulation" />
<theme idref1="T20" idref="T19" />
<cause idref="A3" />
<clue>We have shown previously that trifluoromethylketone inhibitors of cytosolic phospholipase A2 <clueType>suppressed</clueType> interleukin-1beta protein and steady-state mRNA levels <clueLoc>in human lipopolysaccharide-stimulated peripheral blood mononuclear leukocytes</clueLoc>.</clue>
<comment>NER T20 mod</comment>
</event>
<sentence id="S6">In this study, the <term sem="Other" id="T24" lex="subcellular_mechanism">subcellular mechanisms</term> were analyzed by which <term sem="Organic_compound_other" id="T25" lex="trifluoromethylketone">trifluoromethylketones</term> interfere with <term sem="Other" id="T26" lex="gene_expression">gene expression</term>.</sentence>
<event id="E18">
<type class="Negative_regulation" />
<theme idref="T26" />
<cause idref="T25" />
<clue>In this study, the subcellular mechanisms were analyzed by which trifluoromethylketones <clueType>interfere</clueType> <linkTheme>with</linkTheme> gene expression.</clue>
<comment>NER T26 mod</comment>
</event>
<sentence id="S7">We found that they reduced the initial <term sem="Other" id="T27" lex="interleukin-1beta_mRNA_transcription"><term sem="RNA_family_or_group" id="T28" lex="interleukin-1beta_mRNA">interleukin-1beta mRNA</term> transcription</term> rate through prevention of degradation of <term sem="Protein_molecule" id="T29" lex="inhibitor-kappaB_alpha">inhibitor-kappaB alpha</term>.</sentence>
<event id="E19">
<type class="Protein_catabolism" />
<theme idref="T29" />
<clue>We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of <clueType>degradation</clueType> <linkTheme>of</linkTheme> inhibitor-kappaB alpha.</clue>
</event>
<event id="E20">
<type class="Negative_regulation" />
<theme idref="T25" />
<cause idref="E12" />
<clue>We found that <corefCause>they</corefCause> <clueType>reduced</clueType> the initial interleukin-1beta mRNA transcription rate <clueType>through prevention</clueType> <linkTheme>of</linkTheme> degradation of inhibitor-kappaB alpha.</clue>
</event>
<event id="E21">
<type class="Transcription" />
<theme idref="T28" />
<clue>We found that they reduced the initial interleukin-1beta mRNA <clueType>transcription</clueType> rate through prevention of degradation of inhibitor-kappaB alpha.</clue>
</event>
<event id="E22">
<type class="Negative_regulation" />
<theme idref="E21" />
<cause idref="E20" />
<clue>We found that they <clueType>reduced</clueType> the initial interleukin-1beta mRNA transcription rate <linkCause>through</linkCause> prevention of degradation of inhibitor-kappaB alpha.</clue>
</event>
<sentence id="S8">Consequently, <term sem="Other" id="T30" lex="cytosolic_activation">cytosolic activation</term>, <term sem="Other" id="T31" lex="nuclear_translocation"><term sem="Cell_component" id="T40">nuclear</term> translocation</term> and <term sem="DNA_domain_or_region" id="A4">DNA</term>-binding of <term sem="Protein_complex" id="T32" lex="nuclear_factor-kappaB">nuclear factor-kappaB</term> were decreased.</sentence>
<event id="E23">
<type class="Positive_regulation" />
<theme idref="T32" />
<clue>Consequently, <clueLoc>cytosolic</clueLoc> <clueType>activation</clueType>, nuclear translocation and DNA-binding <linkTheme>of</linkTheme> nuclear factor-kappaB were decreased.</clue>
</event>
<event id="E24">
<type class="Localization" />
<theme idref="T32" />
<clue>Consequently, cytosolic activation, <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> and DNA-binding <linkTheme>of</linkTheme> nuclear factor-kappaB were decreased.</clue>
</event>
<event id="E25">
<type class="Binding" />
<theme idref="A4" />
<theme idref="T32" />
<clue>Consequently, cytosolic activation, nuclear translocation and DNA-<clueType>binding</clueType> <linkTheme>of</linkTheme> nuclear factor-kappaB were decreased.</clue>
</event>
<event id="E26">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="E22" />
<clue><linkCause>Consequently</linkCause>, cytosolic activation, nuclear translocation and DNA-binding of nuclear factor-kappaB were <clueType>decreased</clueType>.</clue>
</event>
<event id="E27">
<type class="Negative_regulation" />
<theme idref="E24" />
<cause idref="E22" />
<clue><linkCause>Consequently</linkCause>, cytosolic activation, nuclear translocation and DNA-binding of nuclear factor-kappaB were <clueType>decreased</clueType>.</clue>
</event>
<event id="E28">
<type class="Negative_regulation" />
<theme idref="E25" />
<cause idref="E22" />
<clue><linkCause>Consequently</linkCause>, cytosolic activation, nuclear translocation and DNA-binding of nuclear factor-kappaB were <clueType>decreased</clueType>.</clue>
</event>
<sentence id="S9"><term sem="Organic_compound_other" id="T33" lex="Trifluoromethylketone">Trifluoromethylketones</term> ameliorate chronic <term sem="Other" id="T35" lex="inflammation">inflammation</term> in vivo.</sentence>
<event id="E29">
<type class="Negative_regulation" />
<theme idref="T35" />
<cause idref="T33" />
<clue>Trifluoromethylketones <clueType>ameliorate</clueType> chronic inflammation in vivo.</clue>
</event>
<sentence id="S10">Thus, this therapeutic potency may reside in retention of inactive <term sem="Protein_complex" id="T36" lex="nuclear_factor-kappaB">nuclear factor-kappaB</term> in the <term sem="Cell_natural" id="T37" lex="cytosol">cytosol</term> thereby abrogating <term sem="Other" id="T38" lex="interleukin-1beta_gene_transcription"><term sem="DNA_domain_or_region" id="T39" lex="interleukin-1beta">interleukin-1beta gene</term> transcription</term>.</sentence>
<event id="E30">
<type class="Localization" />
<theme idref="T36" />
<clue>Thus, this therapeutic potency may reside in <clueType>retention</clueType> of inactive nuclear factor-kappaB <clueLoc>in the cytosol</clueLoc> thereby abrogating interleukin-1beta gene transcription.</clue>
</event>
<event id="E31">
<type class="Transcription" />
<theme idref="T39" />
<clue>Thus, this therapeutic potency may reside in retention of inactive nuclear factor-kappaB in the cytosol thereby abrogating interleukin-1beta gene <clueType>transcription</clueType>.</clue>
<comment>NER T39 mod</comment>
</event>
<event id="E32">
<type class="Negative_regulation" />
<theme idref="E31" />
<cause idref="E30" />
<clue>Thus, this therapeutic potency may reside in retention of inactive nuclear factor-kappaB in the cytosol <linkCause>thereby</linkCause> <clueType>abrogating</clueType> interleukin-1beta gene transcription.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
